Form 4: Astrana Health Executive Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Astrana Health's Chief Medical Officer, Dinesh M. Kumar, reported transactions involving common stock, including vesting of performance-based RSUs and tax withholding.
Summary
- Dinesh M. Kumar, Chief Medical Officer of Astrana Health, Inc., reported transactions on April 1, 2026.
- 35,300 shares of common stock were acquired due to the vesting of performance-based restricted stock units (RSUs) that exceeded target performance goals.
- 57,980 shares of common stock were surrendered to offset tax withholding obligations related to vested restricted stock and RSUs.
- Following these transactions, Mr. Kumar beneficially owns 177,655 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine executive stock transactions related to compensation and tax obligations, without significant positive or negative financial implications for the company itself.
Positives
- Performance-based RSUs vested and resulted in an additional 35,300 shares, indicating achievement beyond target performance.
- Mr. Kumar continues to hold a significant number of shares (177,655) after the reported transactions.
Negatives
- 57,980 shares were surrendered to cover tax withholding obligations, reducing the immediate net gain from vested equity.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors, providing transparency into insider stock transactions. The details of vesting and tax withholding are standard components of executive compensation packages in the healthcare technology sector.
Stakeholder Impact
- Shareholders: Increased transparency into insider holdings and transactions. The surrender of shares for tax withholding is a common practice and does not inherently signal a negative outlook.
Next Steps
- Vesting of remaining restricted stock on January 23, 2027.
- Semi-annual vesting of restricted stock units beginning September 5, 2026.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Transaction Date for acquisition and surrender of common stock. |
| 04/03/2026 | Date of signature for the Form 4 filing. |
| 09/05/2026 | First semi-annual installment for vesting of certain restricted stock units. |
| 11/12/2024 | Date of previous Form 4 filing reporting acquisition of performance-based RSUs. |
| 01/23/2027 | Vesting date for certain restricted stock. |
Keywords
Astrana Health, ASTH, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, Vesting, Tax Withholding, Beneficial Ownership, Dinesh M. Kumar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.